about
Recommendations for the treatment of hypertension in patients with DM: critical evaluation based on clinical trials.Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.Dietary and nutraceutical approach to type 2 diabetes.Pioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapyPatient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetesEndothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination.Relationship between serum uric acid and electrocardiographic alterations in a large sample of general population: data from the Brisighella Heart Study.A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular riskBarnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical TrialBarnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus.What do herbalists suggest to diabetic patients in order to improve glycemic control? Evaluation of scientific evidence and potential risks.Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone.Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Studyα-Glucosidase inhibitors and their use in clinical practiceProspects for the development of novel anti-hyperlipidemic drugs.Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials.Improvement of plasma adiponectin, leptin and C-reactive protein concentrations by orlistat: a systematic review and meta-analysisInfluence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rateOptimizing combination treatment in the management of type 2 diabetesA curious case of hypoglycaemia.Olmesartan Combined With Amlodipine on Oxidative Stress Parameters in Type 2 Diabetics, Compared With Single Therapies: A Randomized, Controlled, Clinical Trial.Pioglitazone and rosiglitazone: effects of treatment with a thiazolidinedione on lipids and non conventional cardiovascular risk factors.Effectiveness of hydrochlorothiazide in combination with telmisartan and olmesartan in adults with moderate hypertension not controlled with monotherapy: a prospective, randomized, open-label, blinded end point (PROBE), parallel-arm studyEffects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlled Trial.Effects of thiazolidinediones and sulfonylureas in patients with diabetes.Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patients.Thiazolidinediones plus metformin association on body weight in patients with type 2 diabetes.Efficacy and tolerability of pioglitazone in patients with type 2 diabetes mellitus: comparison with other oral antihyperglycaemic agents.Drug safety evaluation of amlodipine.Nifedipine and telmisartan for the treatment of hypertension: the TALENT study.Dipeptidyl peptidase-4 inhibitors: 3 years of experience.GLP-1 agonists exenatide and liraglutide: a review about their safety and efficacy.Anti-obesity drugs: a review about their effects and their safety.Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review.Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials.Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure.Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea.RETRACTED: Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study.Sulfonylureas and their use in clinical practice.
P50
Q33356154-094D4629-67FB-4BD7-ABFE-FE37E3AED653Q33434303-FDF99634-4C04-45D4-A0B2-B883C9EA2D86Q33466598-8BA03517-994D-4E3F-AFBA-428B07069686Q33701311-D0B8AB92-2F9C-4CA8-8CE9-DDD92BE7A427Q34449858-53158A60-C2B4-4C25-9B4E-FB4EF9B145F1Q35115112-AF851316-CA33-4E18-9210-E97132616BA9Q35210505-EB843C3E-AE27-4708-80E5-65E3C385B911Q35523790-4A60F922-A9B8-42EC-84A5-A1D5258E3EACQ35899381-3ECABB5E-B7B9-4571-9754-3E954D9EF625Q35916952-07DE0776-1C80-4091-855A-7D40E11C989CQ35986588-9A9280EF-D537-4288-B737-92226C42C779Q36018109-064E2534-34B8-4C6C-B305-CA3CD8F5EE9BQ36132575-A6B58B44-58DF-4E02-8136-9B7AF59ACDBBQ36263531-CEB079BC-53C0-44B6-9746-BE3CAED9BBD4Q36423072-FA631C13-DC71-433D-A5E6-B3A534AF1AB2Q36604279-13F24B11-11F4-487D-A1DF-5A28BDEECDD0Q36806626-12D8BC48-BCA7-4A24-9165-600E4FE3F905Q36806635-DB6F7DDD-571D-4CCD-B816-DE47B6DFE8E3Q36829050-F336A915-7681-4A9E-AD40-E26108154E3DQ37031367-0442074D-40BD-4CDF-BC74-34B7F52465C4Q37180098-593597BD-2F69-4A6A-8844-4BE4B25B8425Q37205859-F70B7D9C-2BB0-43C2-AF1C-AC3D11CE8577Q37239221-695DEF03-8B09-4DC9-8AB9-75F80BE4F8CFQ37672785-258F4428-33A5-4992-8F16-62C3525A94F3Q37690832-2D251838-0701-41A3-BDA9-F96FDDDB5473Q37752451-1691771F-CA00-4B4E-B4D1-EB6AC9410D64Q37763201-1766D7B3-61B0-4724-BCCA-D6164B61CD86Q37787411-C99F0B17-1545-4079-B35C-1B1DA7F49118Q37794960-43AB581F-CEB3-4E3B-B001-103E29050B2FQ37876910-DB13CA09-47BF-483E-9841-8B3F6E8EC616Q37959050-CDC23C1B-0461-47D2-9999-D0A14BB46718Q37983085-B1829398-BE31-49C2-BD6D-DB38B385D3B2Q37995334-B9B14878-E9D5-4A93-B4A0-162F8063E0D9Q37996099-40298538-2112-4FFE-ACA5-E01AD6F51277Q38007694-7D1D637F-1044-4F1E-A1C7-5FF4E17F62CCQ38025153-444B8109-026C-4CB6-8949-D4D879AA6CE2Q38113247-819793ED-ABA3-42BA-871E-CB381D9F3F2BQ38172991-30D93C0A-4A71-4B10-83F1-CDA57F8F87F8Q38336973-56091599-93A3-493D-85AE-F9CF122C01CBQ38577058-57032713-51D6-449E-A18B-8D9E5FB8B156
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Giuseppe Derosa
@ast
Giuseppe Derosa
@en
Giuseppe Derosa
@es
Giuseppe Derosa
@nl
Giuseppe Derosa
@sl
type
label
Giuseppe Derosa
@ast
Giuseppe Derosa
@en
Giuseppe Derosa
@es
Giuseppe Derosa
@nl
Giuseppe Derosa
@sl
prefLabel
Giuseppe Derosa
@ast
Giuseppe Derosa
@en
Giuseppe Derosa
@es
Giuseppe Derosa
@nl
Giuseppe Derosa
@sl
P214
P1053
F-2615-2012
P106
P1153
7005336159
P21
P214
P31
P3829
P496
0000-0003-3573-4760
P735
P7859
viaf-311813375